TROXYCA Canadian Trademark Information

On Monday, December 10, 2012, a canadian trademark registration was filed for TROXYCA by Pfizer Inc. *********, **********, ***** ****. The Canadian IP office has given the trademark application number of 1605995. The current status of this trademark filing is Application published. The correspondent listed for TROXYCA is BERESKIN & PARR LLP/S.E.N.C.R. of *********, **********, ***** **** The TROXYCA trademark is filed in the description of Pharmaceutical preparations for the treatment of psychiatric diseases and brain disorders, namely, mood, anxiety and cognitive disorders, Alzheimer's, cerebral palsy, Parkinson's disease, Huntington's disease, growth and thyroid disorders, seizures, brain, central nervous system, ocular motility and spinal cord infections, injuries and diseases, neuromuscular diseases and disorders, degenerative nerve diseases, multiple sclerosis, cranial and facial nerve disorders, tissue injuries, and bone and cartilage injuries, diseases and disorders, pelvic, urological and reproductive system diseases and disorders, namely infections, sexually transmitted diseases, erectile and sexual dysfunction, infertility and incontinence, auto-immune, cardiovascular, gastrointestinal, hematologic, oncological, ophthalmological and respiratory system diseases and disorders, pharmaceutical preparations for the relief of allergies, hypertension, menopause and pain, antibiotics and anti-infectives, anti-inflammatories, anti-fungals, anti-virals, oral and injectectible contraceptives, human vaccines and smoking cessation medications and pharmaceutical sleep aid preparations .